• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
2
Tuberculosis结核病
3
Opportunities and challenges in antimicrobial resistance policy including animal production systems and humans across stakeholders in Argentina: a context and qualitative analysis.阿根廷各利益相关者在包括动物生产系统和人类在内的抗菌药物耐药性政策方面的机遇与挑战:背景与定性分析。
BMJ Open. 2024 Jun 17;14(6):e082156. doi: 10.1136/bmjopen-2023-082156.
4
5
Aquaculture requires special consideration in National Action Plans for Antimicrobial Resistance.在国家抗微生物药物耐药性行动计划中,水产养殖需要特别考虑。
Sci Total Environ. 2025 Jan 1;958:177785. doi: 10.1016/j.scitotenv.2024.177785. Epub 2024 Dec 6.
6
A Qualitative Study on the Design and Implementation of the National Action Plan on Antimicrobial Resistance in the Philippines.菲律宾抗菌药物耐药性国家行动计划设计与实施的定性研究
Antibiotics (Basel). 2022 Jun 17;11(6):820. doi: 10.3390/antibiotics11060820.
7
Progress on the national action plan of Pakistan on antimicrobial resistance (AMR): a narrative review and the implications.巴基斯坦抗菌药物耐药性国家行动计划进展:叙述性综述及影响
Expert Rev Anti Infect Ther. 2022 Jan;20(1):71-93. doi: 10.1080/14787210.2021.1935238. Epub 2021 Jul 26.
8
9
The global governance of antimicrobial resistance: a cross-country study of alignment between the global action plan and national action plans.抗微生物药物耐药性的全球治理:全球行动计划与国家行动计划一致性的跨国研究。
Global Health. 2020 Nov 11;16(1):109. doi: 10.1186/s12992-020-00639-3.
10
India's National Action Plan for antimicrobial resistance - An overview of the context, status, and way ahead.印度抗菌药物耐药性国家行动计划——背景、现状及未来方向概述
J Family Med Prim Care. 2019 Jun;8(6):1828-1834. doi: 10.4103/jfmpc.jfmpc_275_19.

PMID:31287637
Abstract

Antimicrobial resistance (AMR) has serious adverse effects on human, animal and environmental health, healthcare systems, agriculture and national economies. With growing AMR rates, these costs are projected to increase dramatically if no action is taken. International and national efforts to combat AMR have grown steadily over the last two decades and culminated in the adoption of the Global Action Plan on Antimicrobial Resistance in 2015, which asked for all countries to develop national action plans (NAPs) by 2017. However, what has been done so far does not match the recommended scale of actions, and progress with developing NAPs has been inconsistent. Countries have thus been under mounting political pressure either to develop their first AMR NAP or to revise their current plan in line with international guidance. Since the drivers of AMR are multifactorial, AMR NAPs should also be multifactorial, involving a broad range of sectors, including human, animal and environmental health sectors, and utilizing a ‘One Health’ approach. Drawing on guidance from the World Health Organization (WHO), Food and Agricultural Organization of the United Nations (FAO) and World Organisation for Animal Health (OIE), key avenues of action to consider in an effective AMR strategy include: 1. Increasing awareness of AMR. 2. Strengthening surveillance and monitoring, and moving towards national ‘One Health’ surveillance systems. 3. Strengthening antimicrobial stewardship in human health. 4. Strengthening infection prevention and control (IPC) in human health. 5. Strengthening IPC and reducing inappropriate antibiotic use in animals. 6. Limiting the exposure of antimicrobial-resistant pathogens to the environment. 7. Fostering R&D of new antimicrobial therapies, diagnostics and vaccines. Countries will vary in their points of departure and contexts, and their policy responses will therefore differ. However, all these avenues are important and, while some countries may need to prioritize certain avenues initially, all countries should aim towards a comprehensive AMR NAP. Introduction of particular measures within some of these avenues may be obstructed by financial, regulatory and other barriers. However, a recent model developed by the Organisation for Economic Co-operation and Development (OECD) has shown that many policies targeted to tackle AMR are highly cost-effective. Countries should work together to overcome these barriers by sharing their experiences and examples of good practice. While the development of a NAP is an important step in governing the efforts to fight AMR, pursuing their successful implementation remains the biggest challenge. Good governance of AMR policies is thus a key determinant for success and should be at the forefront of any efforts to address the AMR challenge.

摘要